Join the Society for Immunotherapy of Cancer (SITC) President, Dr. James L. Gulley, and the Journal for ImmunoTherapy of Cancer (JITC) Editor-in-Chief, Dr. Michael T. Lotze, for the 2026 World Immunotherapy Council Asia-Pacific Conference!
In collaboration with the Society for Immunotherapy of Cancer (SITC), the 2026 World Immunotherapy Council Asia-Pacific Conference (WIC APAC 2026) will be hosted in conjunction with the Taiwan Society for Immunotherapy of Cancer (TSITC) Annual Meeting and the Taiwan Oncology Society (TOS) Spring Summit on March 28–29, 2026, in Taipei.
The meeting will convene leading experts, medical oncologists, physicians, young investigators, clinical nurses, pharmacists, and researchers in cancer immunotherapy to share cutting-edge science, strengthen regional collaboration, and advance patient care across the Asia-Pacific region.
f
Check out these talks by SITC Speakers...
d
- Guiding the Immune System: Leveraging Therapeutic Cancer Vaccines to Shape Responses in Combination Treatment Strategies
- James L. Gulley, MD, PhD, FACP – National Cancer Institute, SITC President
- The Science of Tumor Infiltrating Lymphocytes (TIL)
- Michael T. Lotze, MD – University of Pittsburgh, JITC Editor-in-Chief
- Bridging Tumor Immune Mechanisms to Clinical Immunotherapy: Emerging Insights and Translational Strategies
- Barbara Seliger, PhD – Martin Luther University Halle-Wittenberg
- Latest Updates on CTLA-4 Blockade and Emerging Combination Strategies
- Paolo Antonio Ascierto, MD – Iistituto Nazionale Tumori IRCCS-Fondazione Pascale
F
Learn more about the program and invited speakers using the link below: